Evidence map›Paper›PMID 34300362›Full record

ArticleJournal of clinical medicine2021

Importance of Lung Ultrasound Follow-Up in Patients Who Had Recovered from Coronavirus Disease 2019: Results from a Prospective Study.

Alba Hernández-Píriz, Yale Tung-Chen, David Jiménez-Virumbrales, Ibone Ayala-Larrañaga, Raquel Barba-Martín, Jesús Canora-Lebrato, Antonio Zapatero-Gaviria, Gonzalo García De Casasola-Sánchez

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. What Is COVID 19 Teaching Us about Pulmonary Ultrasound?Diagnostics (Basel, Switzerland) · 2022
    Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alba Hernández-PírizDepartment of Internal Medicine, Hospital Universitario Fuenlabrada, 28942 Fuenlabrada, Madrid, Spain.ORCID 0000-0003-4492-7644
Yale Tung-ChenDepartment of Internal Medicine, Hospital Universitario Puerta de Hierro, 28222 Majadahonda, Madrid, Spain.ORCID 0000-0002-5613-3609
David Jiménez-VirumbralesIFEMA Field Hospital, 28042 Madrid, Spain.
Ibone Ayala-LarrañagaDepartment of Internal Medicine, Hospital Universitario Fuenlabrada, 28942 Fuenlabrada, Madrid, Spain.
Raquel Barba-MartínDepartment of Medicine, Universidad Rey Juan Carlos, 28933 Móstoles, Madrid, Spain.ORCID 0000-0002-1408-1441
Jesús Canora-LebratoDepartment of Internal Medicine, Hospital Universitario Fuenlabrada, 28942 Fuenlabrada, Madrid, Spain.ORCID 0000-0002-5231-9721
Antonio Zapatero-GaviriaDepartment of Internal Medicine, Hospital Universitario Fuenlabrada, 28942 Fuenlabrada, Madrid, Spain.ORCID 0000-0003-1301-1289
Gonzalo García De Casasola-SánchezIFEMA Field Hospital, 28042 Madrid, Spain.ORCID 0000-0002-5171-7373
Madrid Institute for Advanced Studies · ESHospital Universitario de Fuenlabrada · ESHospital Universitario Puerta de Hierro Majadahonda · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing evidence regarding the imaging findings of coronavirus disease 2019 (COVID-19) in lung ultrasounds, however, their role in predicting the prognosis has yet to be explored. Our objective was to assess the usefulness of lung ultrasound in the short-term follow-up (1 and 3 months) of patients with SARS-CoV-2 pneumonia, and to describe the progression of the most relevant lung ultrasound findings. We conducted a prospective, longitudinal and observational study performed in patients with confirmed COVID-19 who underwent a lung ultrasound examination during hospitalization and repeated it 1 and 3 months after hospital discharge. A total of 96 patients were enrolled. In the initial ultrasound, bilateral involvement was present in 100% of the patients with mild, moderate or severe ARDS. The most affected lung area was the posteroinferior (93.8%) followed by the lateral (88.7%). Subpleural consolidations were present in 68% of the patients and consolidations larger than 1 cm in 24%. One month after the initial study, only 20.8% had complete resolution on lung ultrasound. This percentage rose to 68.7% at 3 months. Residual lesions were observed in a significant percentage of patients who recovered from moderate or severe ARDS (32.4% and 61.5%, respectively). In conclusion, lung injury associated with COVID-19 might take time to resolve. The findings in this report support the use of lung ultrasound in the short-term follow-up of patients recovered from COVID-19, as a radiation-sparing, easy to use, novel care path worth exploring.

Indexed as

coronavirus disease 2019 (COVID-19)lung scorelung ultrasound (LUS)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID34300362
PMCPMC8307687
OpenAlexW3185981741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.